Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19) Ivan Lopez-Mendez; Jorge Aquino-Matus; Sofia Murua-Beltrán Gall; Jose D. Prieto-Nava; Eva Juarez-Hernandez; Misael Uribe; Graciela Castro-Narro;

Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population Rommel Zambrano-Huailla; Laura Guedes; Jose Tadeu Stefano; Arthur A. Arrais de Souza; Sebastián Marciano; Erika Yvamoto; Matheus Truccolo Michalczuk; Denise Siqueira Vanni; Hernan Rodriguez; Flair Jose Carrilho; Mario Reis Alvares-da-Silva; Adrian Gadano; Marco Arrese; Adelina Lozano Miranda; Claudia P. Oliveira;

Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease Shan Hong; Yiwei Hao; Lei Sun; Ping Li; Junru Yang; Fuyang Zhang; Lingling He; Jing Zhang; Hongshan Wei;